Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2020-09-18

First treatment for rare metabolic disorder alkaptonuria

View source ↗

Summary

EMA announces the first approved treatment for alkaptonuria, a rare metabolic disorder, marking a pivotal milestone for patients affected by this condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications